Assembly Biosciences (ASMB) Receivables (2017 - 2026)
Assembly Biosciences (ASMB) recorded Receivables of $822,000 in Q2 2026, up 82.3% from the prior quarter.
Powered by 
Analysis
Assembly Biosciences (ASMB) Receivables (2017 - 2026) Analysis & Trends
At the end of FY2025, Assembly Biosciences reported Receivables of $974,000.
- Annual Receivables has a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $43,000 in FY2023 (-95.4%), $944,000 in FY2022 (+181.0%) and $336,000 in FY2021 (-72.7%).
- Quarterly Receivables has ranged from $43,000 in Q4 2023 to $1.25 million in Q3 2022 over the past five years.
- Peak year-over-year performance for Receivables in the last five years was growth of 181.0% in Q4 2022, against a decline of 95.4% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $451,000 (Q1 2026), $974,000 (Q4 2025) and $912,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Assembly Biosciences | 386.12 Mn | -641.50 Mn | - | 822,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 822,000.00 |
| Mar 31, 2026 | 451,000.00 |
| Dec 31, 2025 | 974,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Jun 30, 2023 | 342,000.00 |
| Mar 31, 2023 | 717,000.00 |
| Dec 31, 2022 | 944,000.00 |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 523,000.00 |
| Mar 31, 2022 | 524,000.00 |
| Dec 31, 2021 | 336,000.00 |
| Sep 30, 2021 | 769,000.00 |
| Jun 30, 2021 | 297,000.00 |
| Mar 31, 2021 | 203,000.00 |
| Dec 31, 2020 | 1.23 Mn |
| Sep 30, 2020 | 3.59 Mn |
| Jun 30, 2020 | 3.32 Mn |
| Mar 31, 2020 | 3.10 Mn |
API Access
Assembly Biosciences Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ASMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ASMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ASMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();